Comparison of the Abbott Architect i2000 assay, the Roche Modular Analytics E170 assay, and an immunoradiometric assay for serum hepatitis B virus markers

Annals of Clinical and Laboratory Science

Volumn 37, Issue 3, 2007, Pages 256-259

  Kim, Hyunjung ^a   Oh, Eun Jee ^a   Kang, Mi Sook ^a   Sung, Hoon Kim ^a   Park, Yeon Joon ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Automated analyzers; Hepatitis B viral markers; Immunoradiometric assay

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ARTICLE; DIAGNOSTIC KIT; HEPATITIS B; IMMUNORADIOMETRIC ASSAY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNORADIOMETRIC ASSAY; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

HEPATITIS B VIRUS;

EID: 34548146753     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107.
2. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of Hepatitis B Virus. J Clin Gastroenterol 2004;38:158-168.
3. Chen Y, Wu W, Li LJ, Lou B, Zhang J, Fan J. Comparison of the results for three automated immunoassay systems in determining serum HBV markers. Clin Chim Acta 2006;372:129-133.
4. Chen CH, Lee CM, Wang JH, Tung HD, Hung CH, Lu SN. Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol 2004;16:1213-1218.
5. Deguchi M, Yamashita N, Kagita M, Asari S, Iwatani Y, Tsuchida T, Iinuma K, Mushahwar IK. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 2004;115:217-222.
6. Ambrosch F, Courouce AM, Coursaget P, et al. Immunization against hepatitis B. Lancet 1988;331:875-876.
7. Wang CW, Wang LC, Chang MH, Ni YH, Chen HL, Hsu HY, Chen DS. Long-term follow-up of hepatitis B surface antibody levels in subjects receiving universal hepatitis B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay. Clin Diagn Lab Immunol 2005;12:1442-1447.
8. Taylor P, Pickard G, Gammie A, Atkins M. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. J Clin Virol 2004;30(Suppl 1):11-15.
9. Oh SH, Choi SK, Park SY, Ki CS. Evaluation of serologic markers for HBV Infection using Roche Modular Analytics E170. J Lab Med Qual Assur 2005;27:167-172.
10. Whang DH, Shin BM. Comparison of four-assay system for the quantification of hepatitis B surface antibody. Korean J Lab Med 2002;22:424-430.
11. Heijtink RA, Schneeberger PM, Postma B, Crombach W. Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/L seroprotection levels unreliable. Vaccine 2002;20:2899-2905.
12. Heijtink RA, Janssen HL, Hop WC, Osterhaus AD, Schalm SW. Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replication. J Med Virol 2001;63:217-219.
13. Heijtink RA, Kruining J, Honkoop P, Kuhns MC, Hop WC, Osterhaus AD, Schalm SW. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B. J Med Virol 1997;53:282-287.